Central Hemodynamics for Risk Reduction Strategies: Additive Value Over and Above Brachial Blood Pressure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|6|730-736

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.6, 2015-02, pp. : 730-736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central Hemodynamics in Risk Assessment Strategies: Additive Value Over and Above Brachial Blood Pressure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 6, 2015-02 ,pp. : 719-729

Bentham Science Publishers

Access to resources Recommend Favorite

Is there any Additional Prognostic Value of Central Blood Pressure Wave Forms Beyond Peripheral Blood Pressure?

By  

Current Pharmaceutical Design, Vol. 15, Iss. 3, 2009-01 ,pp. : 254-266

Bentham Science Publishers

Access to resources Recommend Favorite

Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan

By Barrios Vivencio   Escobar Carlos  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1549-1558

Informa Healthcare

Access to resources Recommend Favorite

Aliskiren: beyond blood pressure reduction

By Riccioni Graziano   Vitulano Nicola   Zanasi Alessandra   Bellocci Fulvio   d'Orazio Nicolantonio  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

Reduction of blood pressure in patients with treatment-resistant hypertension

By Acelajado Maria Czarina   Calhoun David A   Oparil Suzanne  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 2959-2971

Informa Healthcare

Access to resources Recommend Favorite